Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7733953

Concept 2017-03-01 to
2017-08-31
As at
2017-08-31
2017-06-01 to
2017-08-31
As at
2017-02-28
2016-03-01 to
2017-02-28
2016-06-01 to
2016-08-31
2016-03-01 to
2016-08-31
As at
2016-08-31
Key financial data of reporting company
Business results of reporting company
Net sales
73,463,000,000 JPY
145,925,000,000 JPY
74,447,000,000 JPY
Ordinary profit (loss)
12,869,000,000 JPY
28,179,000,000 JPY
12,554,000,000 JPY
Net assets
234,889,000,000 JPY
229,205,000,000 JPY
222,015,000,000 JPY
Total assets
289,387,000,000 JPY
278,820,000,000 JPY
276,155,000,000 JPY
Basic earnings (loss) per share
112.19
68.27
241.27
55.96
109.47
Diluted earnings per share
112.12
241.15
109.42
Equity-to-asset ratio
0.807 xbrli:pure
0.817 xbrli:pure
0.800 xbrli:pure
Net cash provided by (used in) operating activities
16,054,000,000 JPY
19,910,000,000 JPY
10,887,000,000 JPY
Net cash provided by (used in) investing activities
-393,000,000 JPY
1,070,000,000 JPY
-2,197,000,000 JPY
Net cash provided by (used in) financing activities
-3,500,000,000 JPY
-18,402,000,000 JPY
-3,613,000,000 JPY
Cash and cash equivalents
116,454,000,000 JPY
105,610,000,000 JPY
104,380,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.